Jonas Kügler

610 total citations
17 papers, 436 citations indexed

About

Jonas Kügler is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Jonas Kügler has authored 17 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Jonas Kügler's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Protein purification and stability (4 papers). Jonas Kügler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Protein purification and stability (4 papers). Jonas Kügler collaborates with scholars based in Germany, United States and United Kingdom. Jonas Kügler's co-authors include Michael Hust, André Frenzel, Thomas Schirrmann, Stefan Dübel, Doris Meier, Lars Toleikis, Torsten Meyer, Mark Schütte, Saskia Helmsing and Björn Hock and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Applied Microbiology and Biotechnology.

In The Last Decade

Jonas Kügler

16 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Kügler Germany 12 265 246 75 74 53 17 436
Carl A. Ascoli United States 9 370 1.4× 74 0.3× 84 1.1× 14 0.2× 9 0.2× 16 560
Marcela Torres United States 10 303 1.1× 334 1.4× 213 2.8× 24 0.3× 19 0.4× 13 615
Ramesh Baliga United States 9 266 1.0× 151 0.6× 71 0.9× 19 0.3× 30 0.6× 17 378
Edward Dolk Netherlands 10 250 0.9× 168 0.7× 80 1.1× 14 0.2× 30 0.6× 15 431
Richard Chubet United States 7 299 1.1× 131 0.5× 78 1.0× 22 0.3× 47 0.9× 8 542
Michael J. Shields United States 15 246 0.9× 82 0.3× 213 2.8× 37 0.5× 21 0.4× 24 483
Alexander Klimka Germany 11 208 0.8× 192 0.8× 147 2.0× 63 0.9× 67 1.3× 16 413
Simone Muntwiler Switzerland 8 195 0.7× 147 0.6× 130 1.7× 29 0.4× 32 0.6× 11 457
Kellen Schneider India 6 186 0.7× 96 0.4× 162 2.2× 35 0.5× 10 0.2× 7 401
Sally D. Bolmer United States 9 287 1.1× 64 0.3× 73 1.0× 33 0.4× 66 1.2× 13 396

Countries citing papers authored by Jonas Kügler

Since Specialization
Citations

This map shows the geographic impact of Jonas Kügler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Kügler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Kügler more than expected).

Fields of papers citing papers by Jonas Kügler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Kügler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Kügler. The network helps show where Jonas Kügler may publish in the future.

Co-authorship network of co-authors of Jonas Kügler

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Kügler. A scholar is included among the top collaborators of Jonas Kügler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Kügler. Jonas Kügler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sellmann, Carolin, Lukas Pekar, Christina Bauer, et al.. (2020). A One-Step Process for the Construction of Phage Display scFv and VHH Libraries. Molecular Biotechnology. 62(4). 228–239. 23 indexed citations
2.
Dübel, Stefan, Michael Hust, Jonas Kügler, et al.. (2018). Trendbericht Biochemie 2017: Menschliche Antikörper für Medikamente. Nachrichten aus der Chemie. 66(3). 284–290.
3.
Kügler, Jonas, et al.. (2017). Construction of Human Immune and Naive scFv Libraries. Methods in molecular biology. 1701. 3–24. 11 indexed citations
4.
Frenzel, André, Jonas Kügler, Saskia Helmsing, et al.. (2017). Designing Human Antibodies by Phage Display. Transfusion Medicine and Hemotherapy. 44(5). 312–318. 59 indexed citations
5.
Kügler, Jonas, Olivier Armant, Thomas Jaenisch, et al.. (2017). Single amino acid fingerprinting of the human antibody repertoire with high density peptide arrays. Journal of Immunological Methods. 443. 45–54. 32 indexed citations
6.
Kügler, Jonas, Doris Meier, André Frenzel, et al.. (2015). Generation and analysis of the improved human HAL9/10 antibody phage display libraries. BMC Biotechnology. 15(1). 10–10. 100 indexed citations
7.
Frenzel, André, et al.. (2015). Application of M13 phage display for identifying immunogenic proteins from tick (Ixodes scapularis) saliva. BMC Biotechnology. 15(1). 43–43. 18 indexed citations
8.
Frenzel, André, et al.. (2013). Construction of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display. Methods in molecular biology. 215–243. 41 indexed citations
9.
Kügler, Jonas, et al.. (2013). Oligopeptide M13 Phage Display in Pathogen Research. Viruses. 5(10). 2531–2545. 32 indexed citations
10.
Kügler, Jonas, Stefan Schmelz, Juliane Gentzsch, et al.. (2012). High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants. Journal of Biological Chemistry. 287(46). 39224–39232. 20 indexed citations
11.
Kügler, Jonas, et al.. (2008). Identification of immunogenic polypeptides from a Mycoplasma hyopneumoniae genome library by phage display. Applied Microbiology and Biotechnology. 80(3). 447–58. 29 indexed citations
12.
Kügler, Jonas, et al.. (2008). Co‐immobilization of dextransucrase and dextranase for the facilitated synthesis of isomalto‐oligosaccharides: Preparation, characterization and modeling. Biotechnology and Bioengineering. 100(4). 673–683. 22 indexed citations
13.
Haddock, Michael G., Nathan R. Foster, Phillip J. Stella, et al.. (2008). Phase II study of oxaliplatin (OX), 5-fluorouracil (5-FU), and radiation therapy (RT) followed by gemcitabine (GEM) in patients with unresectable pancreatic cancer. Journal of Clinical Oncology. 26(15_suppl). 15553–15553. 2 indexed citations
14.
Alberts, Steven R., J H Donohue, M. R. Mahoney, et al.. (2008). Efficacy and toxicity of cetuximab (C225) plus mFOLOFX6 in patients (pts) with nonoptimally resectable, colorectal metastases (MCRC) confined to the liver. Journal of Clinical Oncology. 26(15_suppl). 15006–15006. 5 indexed citations
15.
McWilliams, Robert R., Nathan R. Foster, Fernando Quevedo, et al.. (2007). NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: Phase II results. Journal of Clinical Oncology. 25(18_suppl). 4578–4578. 3 indexed citations
16.
Henry, David H., Beth Brooks, Jonas Kügler, et al.. (2006). Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.. PubMed. 1(4). 252–60. 36 indexed citations
17.
Kindler, Hedy L., Donald K. Strickland, William Dugan, et al.. (2001). Phase II trial of alimta plus gemzar administered every 21 days in patients with advanced pancreatic cancer. European Journal of Cancer. 37. S311–S311. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026